Intravenous iron treatment in iron-deficient idiopathic pulmonary arterial hypertension, with amendment to compare skeletal muscle strength with healthy controls

Open-label trial of ferric carboxymaltose in Plexogenic Pulmonary Arteriopathy and iron deficiency anemia (IDA) (2 arms), sponsored by Vrije University Medical Center. Primary endpoints: Six-minute walk distance and Contractile force and structure of single quadriceps muscle fibers. Started Jan 2011; status: active, not recruiting.